Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SQI Diagnostics Inc. V.SQD

Alternate Symbol(s):  SQIDF

SQI Diagnostics are leaders in the science of lung health. We develop and manufacture respiratory health and precision medicine tests that run on SQI's automated systems. Our tests simplify and improve COVID19 antibody monitoring, Rapid Acute Lung Injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada and Europe. More than half of its revenues come from the United States.


Recent & Breaking News (TSXV:SQD)

SQI Diagnostics Announces Changes to Its Board of Directors

Business Wire September 30, 2013

SQI Diagnostics Reports Third Quarter Financial Results

Business Wire August 26, 2013

SQI Diagnostics Provides Update on Commercial Milestones with Multiple Global Pharma Projects

Business Wire July 30, 2013

SQI Diagnostics to Extend Warrant Expiry Date

Business Wire July 29, 2013

SQI Diagnostics Announces Executive Promotions

Business Wire June 3, 2013

SQI Diagnostics Reports Second Quarter Financial Results

Business Wire May 21, 2013

SQI Announces Private Placement of up to CDN $3.760 Million

Business Wire April 30, 2013

SQI Diagnostics Reports First Quarter Financial Results

Business Wire February 14, 2013

SQI Diagnostics and Algorithme Pharma to Develop Multiplex Heparin Immunogenicity Assay

Business Wire January 24, 2013

SQI Diagnostics Announces Stock Option Grants

Business Wire January 10, 2013

Canadian small/micro-cap weekend roundup

Stockhouse Editorial November 7, 2009

Junior miner jumps on silver mine acquisition

Sean Mason November 2, 2009